Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for prevention of bone metastasis and disease progression in breast cancer
ChiCTR-TRC-09000408Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of zoledronic acid in breast cancer (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Time to distant metastasis, Overall survival and 1 more. Started Jul 2009; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-TRC-09000408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000408.